Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy.
Bioact Mater
; 13: 223-238, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35224304
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Bioact Mater
Year:
2022
Document type:
Article